Hoba Therapeutics ApS: Financial statements 2023
CVR: 38231170
Source: annual report 2023, Danish Business Authority
01/04/2022 – 31/03/2023
Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -9,429,726 and a net result of DKK -13,930,313 compared with DKK -10,898,671 the year before. Equity in the 2023 report amounted to DKK -32,905,229. The company had 6 employees in the financial year.
- Gross Profit
- DKK -9,429,726
- Profit/Loss
- DKK -13,930,313
- Equity
- DKK -32,905,229
- Total Assets
- DKK 15,287,951
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -9.4M | -13.9M | -32.9M | 6 |
| 2022 | 0 | -7.2M | -10.9M | -19M | 3 |
| 2021 | - | 1.4M | -1.9M | 8.2M | 3 |
| 2020 | - | 839K | -1.6M | 10.1M | 2 |
| 2019 | - | 296K | -1.1M | 11.7M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of December 8, 2023, Marie Allen Schroeder has joined the board of directors of Hoba Therapeutics ApS.
As of December 8, 2023, Gonçalo Nuno Nunes da Silva Rebelo de Andrade has joined the board of directors of Hoba Therapeutics ApS.
As of December 8, 2023, Teit Eliot Johansen has left the board of directors of Hoba Therapeutics ApS.
As of December 8, 2023, Morten Døssing has left the board of directors of Hoba Therapeutics ApS.
As of December 8, 2023, Novo Holdings A/S is registered as an owner of Hoba Therapeutics ApS with an ownership share of 33%.
As of December 8, 2023, Danmarks Eksport- og Investeringsfond is registered as an owner of Hoba Therapeutics ApS with an ownership share of 10%.
As of December 8, 2023, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 10%.
As of December 8, 2023, is registered as an owner of Hoba Therapeutics ApS with an ownership share of 5%.
About Hoba Therapeutics ApS
Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.
